Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Jun 16,2020
Medicilon ion channel screening service
Medicilon has a team of more than 100 chemists, and has experience in research and development cooperation with large pharmaceutical companies and biotechnology companies well-known at home and abroad. Under the leadership of experienced medicinal chemistry leaders, Medicilon provides customers with new drug development services covering a variety of targets and diseases, including from activeRead more
More
Medicilon ion channel screening service
Jun 16,2020
Steps in Generic Drug Development
1. Overview According to the provisions of Annex II of the Drug Registration Management Measures, generic drugs are APIs or preparations that already have national drug standards. Such drugs have been approved for domestic production or marketing. After extensive use at home and abroad, their safety and effectiveness have been obtained. More fully confirmed. 　　Read more
More
Steps in Generic Drug Development
Jun 16,2020
Cell Transfection Technology Service
Cell transfection refers to the technique of introducing foreign molecules such as DNA and RNA into eukaryotic cells. With the continuous development of molecular biology and cell biology research, transfection has become a routine tool for studying and controlling the gene function of eukaryotic cells. It has become more and more widely used in biologicalRead more
More
Jun 16,2020
Medicilon Compound Activity Screening Service
Medici Medicinal Chemistry Service Project Medicilon has completed dozens of drug R&D cooperation projects with domestic and foreign customers, and has successfully found multiple preclinical drug candidates. Medicilon's medicinal chemistry team can provide customers with the following services     Feasibility assessment of new drug targets     High-throughput screening and active compound discovery based on structuralRead more
More
Medicilon Compound Activity Screening Service
Jun 15,2020
Nude mice tumor formation experiment
Medicilon's pharmacology services provide you with experiments on tumor formation in nude mice and subcutaneous tumor formation in nude mice. For details, please contact us. Email: marketing@medicilon.com.cn
More
Nude mice tumor formation experiment
Jun 15,2020
In situ hybridization technology-Shanghai Medicilon
In situ hybridization (insituhybridization) uses a specific labeled nucleic acid of known base sequence as a probe to specifically detect the nucleic acid in tissues and cells in accordance with the principle of complementary base pairing in situ to form a hybrid, which is then labeled with The corresponding monitoring system of the substance canRead more
More
In situ hybridization technology-Shanghai Medicilon
Jun 15,2020
Medicilon’s Pharmaceutical Process Optimization Service
Medicilon’s professional R&D team has rich experience and ability to use sufficient resources, complete production equipment and advanced production facilities, as your long-term strategic partner, to provide customers with high efficiency and maximize production capacity services, saving customers Time and cost to produce reliable and cost-effective intermediate and API products for you. The main R&DRead more
More
Jun 15,2020
Pharmacodynamic research
General principles of pharmacodynamic research: random, controlled, repeated The basic methods of pharmacodynamic research: in vivo test and in vitro test, in which the new drug pharmacodynamic test has been mainly in vivo test, supplemented by in vitro test. Dosing methods for pharmacodynamic studies: prophylactic, therapeutic, and combined prevention and administration Medicilon's Drug Safety EvaluationRead more
More
Pharmacodynamic research
Jun 15,2020
Medicilon Drug Screening Model Service
Drug screening model is an important condition for discovering new drugs. The establishment of new models will drive the emergence of new drugs. The development of molecular biology, cell biology, and computer science, especially the completion of the Human Genome Project, has brought good opportunities for medical research, and also provided many aspects such asRead more
More
Medicilon Drug Screening Model Service
Jun 12,2020
Medicilon Immunogenicity Test Service
Immunogenicity test Immunogenicity test studies include: antibody titer, time of antibody appearance, number of animals with antibody, dose relationship, dynamic change of antibody titer, neutralizing activity of antibody, change of pharmacodynamics, P, and P toxicity during the same period 1. The activation of complement, the deposition of immune complexes in the liver and kidney, theRead more
More
Medicilon Immunogenicity Test Service
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->